Target intelligence / Profile preview

Endothelial activities

Molecular classification
Other
01

Overview

Endothelial activities encompass the diverse physiological and biochemical processes performed by the endothelial cell layer to maintain vascular health and systemic homeostasis. These activities include the regulation of vascular tone through the production of vasodilators like nitric oxide, the control of blood-tissue permeability, the modulation of immune cell adhesion, and the maintenance of a non-thrombogenic surface (Pober & Sessa, 2007; Nature Reviews Immunology). Dysfunction in these activities, often termed endothelial dysfunction, is a critical precursor to cardiovascular diseases, including atherosclerosis and hypertension, and plays a major role in diabetic microvascular complications (Deanfield et al., 2007; Circulation). While 'endothelial activities' is a functional descriptor rather than a specific molecular target, many therapeutic agents aim to improve these processes by acting on specific proteins such as eNOS, ACE, or VEGFR. Consequently, monitoring these activities is essential for assessing vascular health and the efficacy of treatments for inflammatory and ischemic conditions. Because this term refers to a category of biological processes rather than a single receptor or enzyme, it is considered an incorrect designation for a specific molecular drug target (StatPearls, 2023).

Other names
Endothelial functionVascular endothelial activityEndothelial physiological processesVascular homeostasis
02

Mechanism of action

Drugs modulate endothelial activities by enhancing nitric oxide (NO) bioavailability, inhibiting vasoconstrictors like angiotensin II or endothelin-1, or blocking pro-angiogenic growth factors to restore vascular homeostasis and barrier integrity (Gimbrone & García-Cardeña, 2016; Circulation Research).

03

Biological functions

VasodilationAngiogenesisHemostasisVascular permeabilityLeukocyte recruitmentSignal transductionBlood pressure regulation
04

Disease associations

Endothelial dysfunctionCardiovascular diseaseAtherosclerosisHypertensionDiabetes mellitusInflammationSepsis
05

Safety considerations

HypotensionPeripheral edemaThrombosisHemorrhageImpaired wound healing
06

Interacting drugs

Ramipril

5 more in the full profile.

07

Biomarkers

Flow-mediated dilation (FMD)Nitric oxide (NO)Endothelin-1 (ET-1)von Willebrand factor (vWF)Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1)Asymmetric dimethylarginine (ADMA)

Beyond the preview

Go deeper on Endothelial activities.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endothelial activities.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call